What is TG Therapeutics's gross profit?

TG Therapeutics (TGTX) reported gross profit of $171.41M in Q1 2026.

How has TG Therapeutics's gross profit changed year-over-year?

TG Therapeutics's gross profit increased by 62.8% year-over-year, from $105.32M to $171.41M.

What is the long-term trend for TG Therapeutics's gross profit?

Over 2 years (2023 to 2025), TG Therapeutics's gross profit has grown at a 53.2% compound annual growth rate (CAGR), from $219.53M to $515.57M.

TG Therapeutics TGTX Gross Profit

Gross Profit at other companies

BiogenBIIB

$1.82B+0.8%

AbbVieABBV

$10.78B+15.4%

Bristol-Myers SquibbBMY

$8.07B-1.2%

BridgeBio PharmaBBIO

——

Neurocrine BiosciencesNBIX

——

Axsome TherapeuticsAXSM

——

Other financials

Income statement

See full

Revenue$204.9M+69.6%

Operating income$34.8M+304%

Net income$19.8M+291%

EPS (diluted)$0.12+300%

Balance sheet

See full

Cash & equivalents$442.2M+235%

Total debt$753.6M+197%

Total equity$583.1M+146%

Total assets$1.5B+133%

Cash flow

See full

Operating cash flow-$17.9M+37.7%

CapEx$51.0K+104%

Free cash flow-$17.9M+37.6%

Valuation

See full

Market cap$8.15B-14.3%

Enterprise value$8.46B-11.1%

P/E17.6×-225×

P/S11.6×-13.0×

Profitability

See full

Gross margin83.1%-4.4pp

Operating margin21.3%+5.9pp

Net margin66%+55.8pp

FCF margin-6,328.4%+4,773pp

Returns & leverage

See full

Return on equity112.6%+92.9pp

Debt / equity1.3×+0.2×

Current ratio5.8×+1.8×

Where this comes from

Calculated from TG Therapeutics’s reported figures.

$204.9Mtotal revenue−$33.5Mtotal cost of revenue=$171.41M

The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about TG Therapeutics's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TG Therapeutics's gross profit?: TG Therapeutics (TGTX) reported gross profit of $171.41M in Q1 2026.
How has TG Therapeutics's gross profit changed year-over-year?: TG Therapeutics's gross profit increased by 62.8% year-over-year, from $105.32M to $171.41M.
What is the long-term trend for TG Therapeutics's gross profit?: Over 2 years (2023 to 2025), TG Therapeutics's gross profit has grown at a 53.2% compound annual growth rate (CAGR), from $219.53M to $515.57M.